Xue-fei Wu, Li-ye Xie, Fu-wei Lian, Hao-tang Wei, Shu-fang Ning, Bang-li Hu. Integration of clinical and cellular lipidomics identifies a serum metabolite signature predictive of oxaliplatin resistance in colorectal cancer. // Functional & Integrative Genomics. – 2026. – DOI: 10.1007/s10142-026-01868-2. – URL: https://doi.org/10.1007/s10142-026-01868-2
Xue-fei Wu, Li-ye Xie, Fu-wei Lian, Hao-tang Wei, Shu-fang Ning, & Bang-li Hu (2026). Integration of clinical and cellular lipidomics identifies a serum metabolite signature predictive of oxaliplatin resistance in colorectal cancer. Functional & Integrative Genomics. https://doi.org/10.1007/s10142-026-01868-2
Xue-fei Wu, et al. “Integration of clinical and cellular lipidomics identifies a serum metabolite signature predictive of oxaliplatin resistance in colorectal cancer.” Functional & Integrative Genomics, 2026. doi:10.1007/s10142-026-01868-2.
@article{Wu2026,
title = {Integration of clinical and cellular lipidomics identifies a serum metabolite signature predictive of oxaliplatin resistance in colorectal cancer},
author = {Wu, Xue-fei and Xie, Li-ye and Lian, Fu-wei and Wei, Hao-tang and Ning, Shu-fang and Hu, Bang-li},
journal = {Functional \& Integrative Genomics},
year = {2026},
doi = {10.1007/s10142-026-01868-2},
url = {https://doi.org/10.1007/s10142-026-01868-2}
}